Biogen: Solid Enough to Keep Focus on Alzheimer’s, M&A
October 26, 2016 at 14:06 PM EDT
Jefferies' analyst Brian Abrahams and team call Biogen's ( BIIB ) earnings "solid enough to maintain focus on expected near-term newsflow." They explain:
